Thu, Dec 18, 2014, 1:24 AM EST - U.S. Markets open in 8 hrs 6 mins


% | $
Quotes you view appear here for quick access.

Organovo Holdings, Inc. Message Board

  • investsmarty investsmarty Aug 26, 2013 10:06 PM Flag

    ONVO Potential

    If you want to test a drug, the liver processes 99% of all drugs 1st Pass in glucuronidation and the kidney's the remaining 1%. Hence ONVO is hitting the sweet spot with simulating liver (and soon kidney cells). Value in ONVO is in rapid drug screening. This is where ONVO will make ALL it's money is screening small molecules for toxicity for the next 5-10 years. ONVO will start transplanting tissue in disease ridden organs within a decade but that is after some major collaborations not yet on the market. Another area for ONVO : Autodesk & ONVO are working together to use their 3D software to help create structure for the growth of blood vessels which is the first step in creating viable tissue that lasts more than 96 hours.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.91+0.620(+9.86%)Dec 17 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.